Cement
New cement study findings recently were reported by researchers at Ligand Pharmaceuticals, Inc.
Published in Healthcare Finance, Tax and Law Weekly, June 20th, 2007
A new study, "Novel series of potent, nonsteroidal, selective androgen receptor modulators based on 7H-[1,4]oxazino[3,2-g]quinolin-7-ones," is now available. According to a study from the United States, "Recent interest in orally available androgens has fueled the search for new androgens for use in hormone replacement therapy and as anabolic agents. In pursuit of this, we have discovered a series of novel androgen receptor modulators derived from 7H-[1,4]oxazino[3,2-g]quinolin-7-ones."
"These compounds were synthesized and evaluated in competitive binding assays and an androgen receptor transcriptional activation assay. A number of compounds from the series...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
More Articles from Healthcare Finance, Tax and Law Weekly
- AARP New York
Long Island Seniors Rally for Rx Affordable Prescription Drugs and Cell Phone Protections - Accellent Inc.
Stewart A. Fisher Joins KRG Capital Partners, LLC; Alan Bortnick, Vice President - Finance to Lead Accellent's Financial Function - Alcoholism Therapy
Study findings from Johns Hopkins University provide new insights into alcoholism therapy - American Medical Informatics Association
AMIA and AHIMA Applaud House Passage of H.R. 1467, the '10,000 Trained by 2010 Act' - American Nurses Association
ANA and NYSNA Condemn Exploitation of Filipino Registered Nurses - Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Announces Exercise of Initial Purchasers' Option for Additional $75 Million of Convertible Senior Notes - More from this issue of Healthcare Finance, Tax and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
